HealthHIV Medical Education
HealthHIV designs and implements certified medical education that is responsive to the education and training needs of clinicians, allied health workers, the public health workforce, and patients. The dynamic medical education is offered in a variety of formats to a diverse audience of clinicians and allied health professionals.
Education topics include: HIV prevention and PrEP, PrEP navigation, Doxy-PEP, long-acting injectables, HIV care and management, HIV treatment innovation, viral hepatitis, Mpox, LGBTQ health, harm reduction, health equity, and healthcare access.
In support of improving patient care, HealthHIV is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Learn More-
HIV Treatment Innovation Module 5: Management of Treatment-Experienced Patients with HIV Drug Resistance
This module provides information on the latest strategies for managing treatment of patients with HIV drug resistance.
-
HIV Treatment Innovation Module 6: Applying HIV Treatment Individualization in Patient Case Scenarios
This module offers comprehensive patient cases that require learners to apply knowledge from Modules 1-5 in case-based scenarios.
-
HIV Treatment Innovation Module 1: Innovations in Antiretroviral Therapies to Optimize HIV Treatment
This module provides an update on recommended and investigational ARV therapies for optimal HIV care and treatment in HIV care, primary care, and general medicine.
-
HIV Treatment Innovation Module 2: Management of Common Comorbidities for People Living with HIV
This module provides considerations for managing and preventing common comorbidities, co-infections and opportunistic infections among PWH.
-
HIV Treatment Innovation Module 3: Considerations in the Management of HIV in Older Adults
This module provides considerations for managing HIV care among older adults and long-term HIV survivors.
-
HIV Treatment Innovation Module 4: Improving Health Equity in HIV Management
This module provides evidence-based HIV treatment optimization strategies for delivering quality HIV care among key populations.
-
Pharmacist-Led PEP/PrEP: A Comprehensive HIV Prevention Guide and Skills Assessment Activity
This two-part activity will provide continuing pharmacy education (CPE) to pharmacists who contribute or will contribute to HIV prevention, addressing knowledge and practice gaps identified among pharmacists and provide the clinical tools necessary for pharmacists to fulfill active roles within interdisciplinary HIV-prevention teams.
-
Adapting HIV Treatment for People with Substance Use Disorder
In this activity, an expert discusses how to adapt HIV treatment for people with substance use disorders, exploring barriers to management, effective communication strategies, coordinating care with mental health and substance use treatment providers, and guideline recommendations for developing HIV care plans.
-
Improving Equity in PrEP for PEH Through Structural Interventions
Over the course of this 75-minute on-demand webinar, faculty discuss structural interventions to enhance engagement of PEH in PrEP care and improve equity in PrEP access.
-
Special Considerations for PrEP Care Among People Experiencing Homelessness
This 60-minute on-demand webinar features two experts who discuss the unique challenges, opportunities, and strategies for outreach and engagement of people experiencing homelessness (PEH) in PrEP services.
-
Targeting Viral Hepatitis: A Road Map for Providers
Medscape Education, in partnership with HealthHIV and HealthHCV, is pleased to announce the release of an education curriculum featuring expert perspectives on the prevention and management of viral hepatitis.
-
Optimizing HIV and HCV Treatment and Prevention Among People Experiencing Homelessness
On-demand, five-part series provides critical updates on specific recommendations for HIV and HCV treatment and prevention in PEH, including those with opioid use disorder.
